Global Advanced Wound Therapy Devices Market Research Report Forecast to 2023




Advanced Wound Therapy Devices Market Research Report: by Type (Negative Pressure Wound Therapy Systems, Electric Stimulation Devices, Hyperbaric Oxygen Equipment, Pressure Relief Devices, Others), by End-user (Hospitals & Clinics, Home Care Settings, Others), and Region – Global Forecast till 2023
Market analysis

The advanced wound care is one of the emerging sector that offers solutions and devices to manage chronic and acute wounds. Advanced wound therapy devices can treat wounds occured from venous ailment, weight ulcers, diabetes, and others. The developing geriatric people which is powerless to diabetes and peripheral vascular ailment can open up open doors for the market. This can be credited to matured skin hindering recuperating rates. Likewise, improvement of cutting edge gadgets which can facilitate the recuperating procedure in chronic wounds is probably going to support request in the advanced wound therapy devices market. Be that as it may, surprising expenses of these gadgets can compromise its development. The global advanced wound therapy devices market is expected to reach the valuation of USD 2,804.53 million by the year 2023, by growing at a CAGR of 6.70% CAGR during the forecast period (2018-2023).

Market segmentation

The global advanced wound therapy devices market is bifurcated on the basis of its end-user and type. Based on its type, the market is segmented into hyperbaric oxygen equipment, negative pressure wound therapy systems, electric stimulation devices, pressure relief devices, and others. On the basis of its end-users, the market is bifurcated into hospitals & clinics, home care settings, and others.

Regional analysis

Geographically, the global advanced wound therapy devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

KCI Licensing, Inc. (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), DeRoyal Industries, Inc. (U.S.), Medela AG (Switzerland), Perry Baromedical (U.S.), Triage Meditech Pvt. Ltd. (India), and Sechrist (U.S.), Smith & Nephew plc (U.K.), Mölnlycke Health Care AB (Sweden), B. Braun Melsungen AG (Germany), ConvaTec Inc. (U.K.), Cardinal Health (U.S.), among others are some of the major players in the global advanced wound therapy devices market.

Table of Contents

Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Prevalence of Diabetes and Chronic Wounds
4.2.2 Rapidly Growing Geriatric Population
4.2.3 Growing Innovations in Advanced Wound Therapy Devices
4.3 Restraint
4.3.1 High Cost of Advanced Wound Therapy Devices
4.4 Opportunity
4.4.1 Growing Reimbursement for Advanced Wound Therapy Devices
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intense Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Advanced Wound Therapy Devices, By Type
6.1 Introduction
6.1.1 Negative Pressure Wound Therapy Systems
6.1.2 Pressure Relief Devices
6.1.3 Hyperbaric Oxygen Equipment
6.1.4 Electrical Stimulation Devices
6.1.5 Others
7 Global Advanced Wound Therapy Devices Market, By End User
7.1 Introduction
7.1.1 Hospitals and Clinics
7.1.2 Home Care Settings
7.1.3 Others
8 Global Advanced Wound Therapy Devices Market, By Region
8.1 Introduction
8.2 Americas
8.2.1 North America US Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe Germany France UK Italy Spain Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
9 Competitive Landscape
9.1 Company Market Share Analysis
9.1.1 Introduction
10 Company Profiles
10.1 Smith & Nephew
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products/Services Offered
10.1.4 SWOT Analysis
10.1.5 Key Development
10.1.6 Key Strategies
10.2 Mölnlycke Health Care AB
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products/Services Offered
10.2.4 SWOT Analysis
10.2.5 Key Developments
10.2.6 Key strategy
10.3 B. Braun Melsungen AG
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products/Services Offered
10.3.4 SWOT Analysis
10.3.5 Key Developments
10.3.6 Key strategy
10.4 ConvaTec Inc.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products/Services Offered
10.4.4 SWOT Analysis
10.4.5 Key Developments
10.4.6 Key Strategy
10.5 Cardinal Health
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products/Services Offered
10.5.4 SWOT Analysis
10.5.5 Key Developments
10.5.6 Key Strategy
10.6 KCI Licensing, Inc.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products/Services Offered
10.6.4 SWOT Analysis
10.6.5 Key Development
10.6.6 Key Strategy
10.7 Lohmann & Rauscher GmbH & Co. KG
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products/Services Offered
10.7.4 SWOT Analysis
10.7.5 Key Development
10.7.6 Key Strategy
10.8 DeRoyal Industries, Inc.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 SWOT Analysis
10.8.5 Key Development
10.8.6 Key Strategy
10.9 Medela AG
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products/Services Offered
10.9.4 SWOT Analysis
10.9.5 Key Development
10.9.6 Key Strategy
10.1 Perry Baromedical
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products/Services Offered
10.10.4 SWOT Analysis
10.10.5 Key Development
10.10.6 Key Strategy
10.11 Triage Meditech Pvt. Ltd.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Products/Services Offered
10.11.4 SWOT Analysis
10.11.5 Key Development
10.11.6 Key Strategy
10.12 Sechrist
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Products/Services Offered
10.12.4 SWOT Analysis
10.12.5 Key Development
10.12.6 Key Strategy
11 Appendix
11.1 Discussion Blue Print

Additional information


Geography Covered

Date Published